Determination of the C-7,9,12,13,17 and 18 stereochemistries of tautomycetin. Synthesis of the tautomycetin degradation product

Tetrahedron Letters

Volumn 37, Issue 4, 1996, Pages 491-494

  Dai, Jian Ping ^a   Sodeoka, Mikiko ^a   Shibasaki, Masakatsu ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TAUTOMYCETIN;

ARTICLE; DRUG STRUCTURE; DRUG SYNTHESIS; NUCLEAR MAGNETIC RESONANCE; STEREOCHEMISTRY;

EID: 0030052665     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/0040-4039(95)02188-4     Document Type: Article

References (30)

1. (a) Chen, X.-C.; Kihara, T.; Ying, X.; Uramoto, M.; Osada, H.; Kusakabe, H.; Wang, B.-N.; Kobayashi, Y.; Ko, K.; Yamaguchi, I.; Shen, Y.-C.; Isono, K. J. Antibiotics. 1989, 42, 141.
2. (b) Chen, X.-C.; Ubukata, M.; Isono, K. J. Antibiotics. 1990, 43, 890.
3. Sakuda, S.; Miki, K.; Kitaoka, S.; Reugjitchachawaly, M.; Yamada, Y. Biosci. Biotech. Biochem. 1995, 59, 133.
4. (a) Chen, X.-C.; Kihara, T.; Kusakabe, H.; Magae, J.; Kobayashi, Y.; Fang, R.-P.; Ni, Z.-F.; Shen, Y.-C.; Ko, K.; Yamaguchi, I.; Isono, K. J. Antibiotics. 1987, 40, 907.
5. (b) Chen, X.-C.; Ubukata, M.; Isono, K. J. Antibiotics. 1990, 43, 809. For other biological and synthetic studies of tautomycin, see:
6. (c) Oikawa, M.; Ueno, T.; Oikawa, H.; Ichikawa, A. J. Org. Chem. 1995, 60, 5048,
7. (d) Ichikawa, Y.; Tsuboi, K.; Jiang, Y.; Naganawa, A.; Isobe, M. Tetrahedron Lett. 1995, 36, 7101.
8. (e) Nakamura, S.; Shibasaki, M. Tetrahedron Lett. 1994, 35, 4145, and references cited therein.
9. For preparation of 8a-d, see: (a) Romo, D.; Johnson, D. D.; Plamondon, L.; Miwa, T.; Schreiber, S. L. J. Org. Chem. 1992, 57, 5060.
10. (b) Evans, D. A.; Morrissey, M. M.; Dow, R. L. Tetrahedron Lett. 1985, 26, 6005.
11. (c) Johnson, M. R.; Kishi, Y. Tetrahedron Lett. 1979, 20, 4343.
12. 2, -78°C, 82-88%. For stereoselective methylation, see: (a) Brown, J. M. Angew. Chem. Int. Ed. Engl. 1987, 26, 190.
13. 2O (20:1), 83%. For inversion of the β-hydroxy group, see (b) Torisawa, Y.; Okabe, H.; Ikegami, S. Chem. Lett. 1984, 1555.
14. (c) Huffman, J. W.; Desai, R. C. Synth. Commun. 1983, 13, 553.
15. (d) Kruizinga, W. H.; Strijtveen, B.; Kellog, R. M. J. Org. Chem. 1981, 46, 4321.
16. (a) Evans, D. A.; Bartroli, J.; Shih, T. L. J. Am. Chem. Soc. 1981, 103, 2127.
17. (b) Evans, D. A.; Dow R. L. Tetrahedron Lett. 1986, 27, 1007.
18. (c) Evans, D. A.; Polniaszek, R. P. Tetrahedron Lett. 1986, 27, 5683.
19. (d) Hayashi, K.; Hamada, Y.; Shioiri,T. Tetrahedron Lett. 1991, 32, 7287.
20. Synthesized diastereomers: 7R,9S,12S,13S,17S,18R; 7R,9S,12R,13S,17S,18R; 7R,9S, 12S,13S,17R,18S; 7R,9S, 12R, 13S,17R, 18S; 7S,9R, 12S,13S,17S,18R; 7S,9R, 12R, 13S,17S,18R;7S,9R, 12S,13S,17R,18S; 7S,9R, 12R, 13S,17R, 18S; 7R,9R,12S/R,13S,17S, 18R; 7S,9R, 125/R,13S,17S,18S; 7S,9R,12S/R,13S,17R,18R.
21. (a) Corey, E. J.; Katzenellenbogen, J. A. J. Am. Chem. Soc. 1969, 91, 1851.
22. (b) Siddall, J. B.; Biskup, M.; Fried, J. H. J. Am. Chem. Soc. 1969, 91, 1853.
23. (c) Bowlus, S. B.; Katzenellenbogen, J. A. J. Org. Chem. 1973, 38, 2733.
24. (d) House, H. O.; Chu, C.-Y.; Wilkins, J. M.; Umen, M. J. J. Org. Chem. 1975, 40, 1460.
25. (e) Piers, E.; Chong, J. M.; Morton, H. E. Tetrahedron 1989, 45, 363.
26. 4 reagent gave 12a as a major diastereoisomer See: Noyori, R.; Tomino, I.; Yamada, M.; Nishizawa, M. J. Am. Chem. Soc. 1984, 106, 6717.
27. (a) Blanchette, M. A.; Choy, W.; Davis, J. T. Tetrahedron Lett. 1984, 25, 2183.
28. (b) Yamashita, M.; Kato, Y.; Suemitsu, R. Chem. Lett. 1980, 847.
29. 2, rt; iii. TBSCI, imidazole, DMF, rt, 40%, 2 steps). (formula presented)
30. 3).